Skip to main content
. 2018 Jun 5;16:12. doi: 10.1186/s12959-018-0166-4

Fig. 4.

Fig. 4

Comparison of mean PAI-1 antigen levels (ng/mL) in patients with primary and secondary major adverse cardiac events and control patients. Data is expressed as a mean difference and analyzed using a random effects model. a PAI-1 levels (ng/mL) in patients with primary major adverse cardiac events. b PAI-1 levels (ng/mL) in patients with secondary major adverse cardiac events